Insider Transactions in Q4 2021 at Guardant Health, Inc. (GH)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 10
2021
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$468,730
$95.59 P/Share
|
Dec 10
2021
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
Nov 23
2021
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
54,500
+0.49%
|
$5,123,000
$94.97 P/Share
|
Nov 23
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
54,500
+0.46%
|
$5,123,000
$94.93 P/Share
|
Nov 19
2021
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+1.37%
|
$4,900,000
$98.3 P/Share
|
Nov 19
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+1.3%
|
$4,900,000
$98.33 P/Share
|
Nov 10
2021
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$523,004
$106.38 P/Share
|
Nov 10
2021
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
Oct 11
2021
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$508,202
$103.59 P/Share
|
Oct 11
2021
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|